New In-Body CAR-T therapy targets Hard-to-Treat blood cancer
NCT ID NCT07322159
First seen Jan 09, 2026 · Last updated Apr 23, 2026 · Updated 19 times
Summary
This early study tests a new treatment called IASO206 for people with multiple myeloma that has come back or stopped responding to standard therapies. The treatment is a type of CAR-T therapy that works inside the body to help immune cells attack cancer. About 12 adults aged 18-75 will take part to see if it is safe and shows signs of shrinking the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.